By Nicholas G. Miller
Shares of Organon fell after the company reported fourth-quarter earnings below analysts' expectations.
The stock fell 13% to $6.67 and is down 55% over the past 12 months.
The company swung to a loss of $205 million, or 79 cents a share, from a profit of $109 million, or 42 cents a share, the year prior.
Adjusted earnings were 63 cents a share. Analysts polled by FactSet expected 73 cents a share.
Revenue fell 5% to $1.51 billion. Wall Street expected $1.53 billion.
Write to Nicholas G. Miller at nicholas.miller@wsj.com.
(END) Dow Jones Newswires
February 12, 2026 10:10 ET (15:10 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.